All PlansCoverageLow impact
Cytochrome P450 Genotype-Guided Treatment Strategy
Blue Cross & Blue Shield of Mississippi·MS·Medical Policy
We identified it
Jun 20, 2026
Summary
New medical policy A.2.04.38 establishes coverage guidelines for cytochrome P450 genotype testing to guide drug treatment strategies. The policy provides background on pharmacogenomics and CYP450 testing but appears to be incomplete as it cuts off mid-sentence without stating specific coverage criteria or billing requirements.
Action Required
Monitor for the complete policy document release as this appears to be a partial policy text that cuts off before coverage determinations and billing guidelines are provided. Contact BCBS Mississippi for the full policy text to understand actual coverage criteria and coding requirements.